Johnson & Johnson (NYSE:JNJ) early Tuesday posted mixed first quarter earnings results, but said its guidance remains unchanged as it works to fully integrate a big recent acquisition.
Written by StockNews.com
The New Brunswick, NJ-based diversified healthcare giant reported:
Looking ahead, JNJ said that:
The company also commented that it remains on track to hit its previously announced earnings forecast:
“Johnson & Johnson’s first-quarter results are in line with our expectations and we are confident we will achieve the full-year financial guidance we established at the beginning of the year.”
Johnson & Johnson shares rose $0.19 (+0.15%) in premarket trading Tuesday. Year-to-date, JNJ had gained 9.84% prior to today’s report, versus a 5.40% rise in the benchmark S&P 500 index during the same period.
JNJ currently has a StockNews.com POWR Rating of A (Strong Buy), and is ranked #1 of 135 stocks in the Medical – Pharmaceuticals category.
No Comments